Andrew L. Zydney is Bayard D. Kunkle Chair and Professor of Chemical Engineering at The Pennsylvania State University, having served as Head of that Department from 2004-2014. Professor Zydney's research is focused on membranes and bioprocessing, with a particular emphasis on the development of membrane systems for the purification of monoclonal antibodies, vaccines, and gene therapy products.
He has published more than 260 articles on these topics, including invited contributions to the Encyclopedia of Bioprocess Technology and the Handbook of Biomedical Engineering. He is an elected a Fellow of the American Institute of Medical and Biological Engineers (AIMBE), the American Institute of Chemical Engineers (AIChE), the American Association for the Advancement of Science (AAAS), and the Industrial & Engineering Chemistry Division of ACS. Zydney is also co-founder of Chromatan Corp., a start-up company focused on the development of continuous countercurrent tangential chromatography for purification of biopharmaceuticals.